Memorandum of Agreement between the Dangerous Drugs Board and the Public Attorney's Office
OCA Circular No. 224-2016 informs all judges of the Regional Trial Court about a Memorandum of Agreement (MOA) dated August 22, 2016, between the Dangerous Drugs Board (DDB) and the Public Attorney's Office (PAO). This agreement aims to facilitate the implementation of Section 54 of the Comprehensive Dangerous Drugs Act of 2002, allowing drug dependents to voluntarily submit for treatment and rehabilitation. The DDB will coordinate with the PAO to provide legal assistance to drug dependents, while the PAO will represent these individuals in court as needed. The MOA outlines the responsibilities of both parties and is effective unless modified or terminated with proper notice.
Quick Answers
- What is Memorandum of Agreement between the Dangerous Drugs Board and the Public Attorney's Office about?
- OCA Circular No. 224-2016 informs all judges of the Regional Trial Court about a Memorandum of Agreement (MOA) dated August 22, 2016, between the Dangerous Drugs Board (DDB) and the Public Attorney's Office (PAO). This agreement aims to facilitate the implementation of Section 54 of the Comprehensive Dangerous Drugs Act of 2002, allowing drug dependents to voluntarily submit for treatment and rehabilitation. The DDB will coordinate with the PAO to provide legal assistance to drug dependents, while the PAO will represent these individuals in court as needed. The MOA outlines the responsibilities of both parties and is effective unless modified or terminated with proper notice.
- What type of law is OCA Circular No. 224-2016?
- Memorandum of Agreement between the Dangerous Drugs Board and the Public Attorney's Office (OCA Circular No. 224-2016) is a Philippine Supreme Court Issuances enacted by the Congress of the Philippines.
- When was Memorandum of Agreement between the Dangerous Drugs Board and the Public Attorney's Office enacted?
- Memorandum of Agreement between the Dangerous Drugs Board and the Public Attorney's Office (OCA Circular No. 224-2016) was enacted on Oct 21, 2016.
- What is the citation for Memorandum of Agreement between the Dangerous Drugs Board and the Public Attorney's Office?
- Memorandum of Agreement between the Dangerous Drugs Board and the Public Attorney's Office, OCA Circular No. 224-2016, Oct 21, 2016 (Philippines)
Law Information
- Reference Number
- OCA Circular No. 224-2016
- Date Enacted
- Category
- Supreme Court Issuances
- Subcategory
- Office of the Court Administrator Circulars
- Jurisdiction
- Philippines
- Enacting Body
- Congress of the Philippines
Full Law Text
October 21, 2016
OCA CIRCULAR NO. 224-2016
| TO | : | All Judges of the Regional Trial Court |
| SUBJECT | : | Memorandum of Agreement between the Dangerous Drugs Board and the Public Attorney's Office |
Appended herein as Annex "A", for the information and guidance of all judges of the Regional Trial Court, is a Memorandum of Agreement dated 22 August 2016 between the Dangerous Drugs Board and the Public Attorney's Office in relation to Section 54 (Voluntary Submission of a Drug Dependent to Confinement, Treatment and Rehabilitation), article VIII of Republic Act No. 9165 or the Comprehensive Dangerous Drugs Act of 2002, as amended.
(SGD.) RAUL BAUTISTA VILLANUEVADeputy Court Administrator andOfficer-in-ChargeOffice of the Court Administrator
ANNEX A
MEMORANDUM OF AGREEMENT
KNOW ALL MEN BY THESE PRESENTS:
This Memorandum of Agreement made and entered into this 22nd day of August, 2016 at Quezon City, Philippines, by the following parties: cDHAES
The DANGEROUS DRUGS BOARD, a government agency created by virtue of Republic Act No. 9165, otherwise known as the Comprehensive Dangerous Drugs Act of 2002, with principal office address at 3rd Floor, DDB — PDEA Building, NIA Road, Diliman, Quezon City, represented herein by its CHAIRMAN, SECRETARY FELIPE L. ROJAS, JR., CEO VI, hereinafter referred to as the DDB;
and
The PUBLIC ATTORNEY'S OFFICE, the principal law office of the Government in extending free legal assistance to indigent persons in criminal, civil, labor, administrative and other quasi-judicial cases, with principal office address at DOJ Agencies Building, NIA Road, Diliman, Quezon City, represented herein by its CHIEF PUBLIC ATTORNEY, DR. PERSIDA V. RUEDA-ACOSTA, hereinafter referred to as the PAO.
WITNESSETH: THAT —
WHEREAS, pursuant to Sec. 77 of RA No. 9165 or the Comprehensive Dangerous Drugs Act of 2002, as amended, the DDB is the policy-making and strategy-formulating body on drug prevention and control and shall develop and adopt a comprehensive, integrated, unified and balanced national drug abuse prevention and control strategy;
WHEREAS, Sec. 54 of RA No. 9165 states that any drug dependent or relative within the fourth degree of consanguinity or affinity may apply to the Board or its duly — recognized representatives for treatment and rehabilitation;
WHEREAS, Sec. 81 (q) of RA No. 9165 provides that the DDB has the power and duty to issue guidelines for the approval and disapproval of applications for voluntary treatment, rehabilitation and confinement, wherein it shall issue the necessary guidelines, rules and regulations pertaining to the application and enforcement thereof; ASEcHI
WHEREAS, to effectively carry out the implementation of the Voluntary Submission Program pursuant to RA No. 9165, Board Resolution No. 2, Series of 2002 authorized the Executive Director to designate duly authorized Board Representatives to accept applications and file petitions for voluntary submission and compulsory confinement;
WHEREAS, Sec. 3 (a) of Board Regulation No. 3, Series of 2007 states that authorized representatives shall be assisted by the Department of Justice, through the PAO, in the performance of their delegated authority;
WHEREAS, Sec. 14 — A of Chapter V, Title III, Book IV of Executive Order No. 292, otherwise known as the "Administrative Code of 1987" provides that the PAO shall independently discharge its mandate to render, free of charge, legal representation, assistance and counseling to indigent persons in criminal, civil, labor, administrative and other quasi-judicial cases;
WHEREAS, pursuant to the aforementioned law, in the exigency of service, the PAO may be called upon by proper government authorities to render such service to other persons, subject to existing laws, rules and regulations;
WHEREAS, the PAO is willing to assist the DDB relative to the implementation of RA No. 9165 by providing technical and legal assistance to drug dependents who wish to avail of the provisions of Section 54 of said law;
NOW, THEREFORE, for and in consideration of the foregoing, the PARTIES agree as follows:
A. DUTIES AND RESPONSIBILITIES OF DDB
1. Coordinate with PAO regarding voluntary submission cases falling under RA No. 9165 for the effective implementation of this AGREEMENT; ITAaHc
2. Provide information to PAO relative to the case status of drug dependents referred to the same office;
3. Involve PAO in relevant DDB trainings and seminars; and,
4. Monitor and evaluate the implementation of this AGREEMENT.
B. DUTIES AND RESPONSIBILITIES OF PAO
1. For the Public Attorneys to act as counsel and appear before the courts for drug dependents on petitions for voluntary submission filed by the DDB or its authorized representatives, except when there is conflict of interest and without prejudice to the drug dependent's right to be represented by a private counsel of his choice;
2. In the exigency of the service, Public Attorneys shall provisionally represent the drug dependent who may appear in court by reason of a Petition for Voluntary Submission but has not yet been able to acquire the services of a counsel; and CHTAIc
3. Recommend measures or strategies to effectively implement this AGREEMENT.
This AGREEMENT shall take effect upon approval of the PARTIES and shall be in effect unless and until modified and/or abrogated by a subsequent AGREEMENT of the parties. In case of non-compliance of the provisions by one party, any aggrieved party may terminate this AGREEMENT by sending a written notice to the other parties at least thirty (30) days prior to the proposed date of termination.
(SGD.) SEC. FELIPE L. ROJAS, JR., CEO VI
(SGD.) DR. PERSIDA V. RUEDA-ACOSTA
SIGNED IN THE PRESENCE OF:
ACKNOWLEDGMENT
REPUBLIC OF THE PHILIPPINES)
BEFORE ME, a Notary Public, this August 22, 2016 personally appeared the following persons:
FELIPE L. ROJAS, JR.
PERSIDA V. RUEDA-ACOSTA
Known to me to be the same persons who executed the foregoing AGREEMENT consisting of three (3) pages, including the page on which this acknowledgment is written, and acknowledged to me that the same is their free act and deed and that of the entities which they represent.
WITNESS MY HAND AND SEAL.
Doc. No.:
Cite This Law
Memorandum of Agreement between the Dangerous Drugs Board and the Public Attorney's Office, OCA Circular No. 224-2016, Oct 21, 2016 (Philippines)
Memorandum of Agreement between the Dangerous Drugs Board and the Public Attorney's Office, OCA Circular No. 224-2016 (Phil. 2016)
Related Laws
- Custody and Disposition of Seized Dangerous Drugs and Controlled ChemicalsOCA Circular No. 51-03 • May 15, 2003 • Supreme Court Issuances
- Guidelines on the Custody and Disposition of Seized Dangerous Drugs, Controlled Precursors and Essential Chemicals, and Laboratory EquipmentDangerous Drugs Board Regulation No. 1-02 • Oct 18, 2002 • Other Rules and Procedures
- Custody and Disposition of Seized Dangerous Drugs and ParaphernaliaDangerous Drugs Board Regulation No. 2-00 • Other Rules and Procedures
- Inclusion of Ketamine in the List of Dangerous DrugsDangerous Drugs Board Regulation No. 3-05 • Jul 19, 2005 • Other Rules and Procedures
- Guidelines on the Disposition of Confiscated, Seized and/or Surrendered Dangerous Drugs, Plant Sources of Dangerous DrugsDDB Board Regulation No. 01-07 • Mar 20, 2007 • Other Rules and Procedures
- Comprehensive Guidelines on Importation of, and Other Lawful Acts in Connection with any Dangerous Drugs, etc.Dangerous Drugs Board Regulation No. 3-03 • Jul 4, 2003 • Other Rules and Procedures
Browse More Supreme Court Issuances
Explore other laws in the Supreme Court Issuances category.
View All Supreme Court IssuancesNeed Help Understanding This Law?
Ask our AI assistant to explain provisions, implications, or related laws.
Ask AI About This Law